Bavo Heeman

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicing.

Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicing.

Journal: Acta neuropathologica

Published: March 28, 2025

Methylome analysis of FTLD patients with TDP-43 pathology identifies epigenetic signatures specific to pathological subtypes.

Methylome analysis of FTLD patients with TDP-43 pathology identifies epigenetic signatures specific to pathological subtypes.

Journal: Molecular neurodegeneration

Published: December 10, 2024

Increased TMEM106B levels lead to lysosomal dysfunction which affects synaptic signaling and neuronal health.

Increased TMEM106B levels lead to lysosomal dysfunction which affects synaptic signaling and neuronal health.

Journal: Molecular neurodegeneration

Published: August 28, 2024

Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology.

Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology.

Journal: Acta neuropathologica

Published: March 13, 2023

Correction to: Accumulation of TMEM106B C‑terminal fragments in neurodegenerative disease and aging.

Correction to: Accumulation of TMEM106B C‑terminal fragments in neurodegenerative disease and aging.

Journal: Acta neuropathologica

Published: January 06, 2023

C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes.

C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes.

Journal: Brain : a journal of neurology

Published: December 13, 2022

Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.

Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.

Journal: Acta neuropathologica

Published: October 24, 2022

Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.

Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.

Journal: Cell

Published: January 25, 2022

Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder.

Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: October 13, 2021

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.

Journal: Acta neuropathologica communications

Published: October 21, 2020

Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.

Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.

Journal: Acta neuropathologica

Published: December 07, 2019

Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability.

Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability.

Journal: Acta neuropathologica

Published: December 03, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026